The sales are immaterial in size and executed under pre-arranged 10b5-1 plans. No signal for stock direction. Monitor next earnings or pipeline catalyst for material insider activity.
ORKA drugs
ORKA drug pipeline →Price Chart
How similar events traded
Executive Summary
Two insiders at Oruka Therapeutics (ORKA) executed open-market sales totaling $173K on November 12, 2026, both under 10b5-1 plans. Director Kristine M. Ball sold $122K and SVP Arjun Agarwal sold $51K. The combined sales represent less than 0.01% of the company's $7.3B market cap, making the cluster trivial in scale.
Key Financial Metrics
Key Facts
- Two insiders sold shares on November 12, 2026
- Director Kristine M. Ball sold 1,200 shares for $122,108 (10b5-1 plan)
- SVP Arjun Agarwal sold 500 shares for $50,988 (10b5-1 plan)
- Total open-market sales: $173,096
- Sales represent less than 0.01% of $7.3B market cap
- Both sales were under 10b5-1 trading plans
Financial Impact
Total insider sales of $173K, negligible relative to $7.3B market cap
Risk Factors
- Sales are trivial and routine; no material risk identified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1794618268500 |
Track record
40 reports on ORKA
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Viewing Entry $104.89 Now $99.24 −5.39% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers